The source of ultrasound contrast effect
โ Scribed by Richard S. Meltzer; E. Glenn Tickner; Thomas P. Sahines; Richard L. Popp
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 647 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0091-2751
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Evidence that microbubbles are the main sources of ultrasound contrast in injected solutions has been largely indirect. To investigate this directly, we examined freshly agitated indocyanine green, freshly agitated water, commercially prepared precision microbubbles (diameter 75 ยฑ 25 ฮผ) in gelatin, carbonated water, โdegassedโ indocyanine green solution, and โdegassedโ water in one or more of four different assay systems. Only fluids with microbubbles produced ultrasound contrast. Injected contrast material rose in a water bath at a rate that identified it as being caused by microbubbles. Indocyanine green and gelatin surface tensions were measured and found to be low (43 dynes/cm^2^), thus explaining their tendency to stabilize the microbubbles that cause ultrasound contrast effect when injected and to hold foam after agitation. The force of hand injections (force similar to that used clinically through catheters and 19โgauge or 23โgauge needles) was below the force needed to cause cavitation or ultrasound contrast effect. Microbubble content could be quantified by the decrease in amplitude of the echo from a structure distant to the microbubbles. We conclude that the ultrasound contrast effect seen in peripherally injected fluids is caused by microbubbles present in the injectant. The contrast is not due to cavitation at needle tips, and it can be quantified over a limited range. Improved design for a peripheral contrast agent is suggested.
๐ SIMILAR VOLUMES
A standardization procedure for in vitro acoustic characterization of ultrasound contrast agents is presented. One new acoustic parameter for particular importance is retained: This is STAR, scattering-to-attenuation ratio, for quantification of the effectiveness of the contrast agent. The STAR expr
## BACKGROUND. Prostate cancer, suspected by serum prostate-specific antigen (PSA) elevation and/or digital abnormalities, is not always evident on gray-scale or color Doppler transrectal ultrasound (TRUS). EchoGen (Sonus Pharmaceuticals, Inc., Bothell, WA), a blood vessel image enhancer able to v
## Abstract This report describes an investigation into factors affecting the degradation of novel poly(lacticโ__co__โglycolic acid) (PLGA) contrast agents. Contrast agents fabricated by two different methods and varying in acoustic properties were compared. The effect of ultrasound frequency (5 an